E 717 (Meprobamate 400 mg)
Pill imprint E 717 has been identified as Meprobamate 400 mg.
Meprobamate is used in the treatment of anxiety and belongs to the drug class miscellaneous anxiolytics, sedatives and hypnotics. FDA has not classified the drug for risk during pregnancy. Meprobamate 400 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
- E 717
- 400 mg
- Prescription only
- Drug Class:
- Miscellaneous anxiolytics, sedatives and hypnotics
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- 4 - Some potential for abuse
- United Research Laboratories/Mutual Pharmaceutical Company
More about meprobamate
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.